Good evening, here are the coronavirus updates you need to know tonight.
- Doses of Canada’s first COVID-19 vaccine arrive shortly (and if you have these allergies, you should skip the shot)
- How six Canadian charities have adapted to COVID-19′s chilling effects
- Canada’s history shows that, when it comes to vaccination, details matter
Worth watching: Facebook Live Q&A on coronavirus vaccines
Science reporter Ivan Semeniuk and health reporter Kelly Grant will answer reader questions on Facebook live on Tues., Dec. 15 at 1 p.m. ET.
- When: Tuesday, Dec. 15 at 1:00 p.m. ET
- Where: The Globe and Mail’s Facebook page
- Send questions to firstname.lastname@example.org
In Canada, there have been at least 454,847 cases reported. In the last week 45,325 new cases were announced, 3 per cent more than the previous week. There have also been at least 368,474 recoveries and 13,350 deaths. Health officials have administered more than 14,248,812 tests.
Photo of the day
Coronavirus in Canada
First doses of Pfizer-BioNTech’s COVID-19 vaccine are set to arrive in Canada on flights today and tomorrow, Major-General Dany Fortin, a former NATO commander who is leading the distribution of vaccines, told the CBC today. Yesterday, Health Canada warned that people allergic to ingredients in the COVID-19 vaccine should forgo getting the shots.
- Ontario is reporting another 16 deaths related to COVID-19 and 1,677 new infections today, down from 1,873 yesterday.
- Quebec has recorded 1,994 new cases of COVID-19 today and 33 additional deaths linked to the virus. The regions with the most new infections were Montreal with 748, the Quebec City area with 235, and Monteregie, south of Montreal, with 196.
- New cases of COVID-19 in the Atlantic provinces rose again by single digits, health authorities reported today. Nova Scotia added six and New Brunswick two.
- COVID-19 is straining Manitoba patients awaiting surgery. The provincial government says its booking service that’s making appointments for eligible health-care workers to get COVID-19 vaccinations has received more than 100,000 phone calls since opening yesterday. But there are only 900 spots available.
Coronavirus around the world
- Germany will close most stores from Wednesday until at least Jan. 10, cutting short the busy Christmas shopping season, as it tightens coronavirus restrictions and tries to rein in the spread of the disease, Chancellor Angela Merkel said today.
- The first shipments of a COVID-19 vaccine for widespread use in the United States headed today from Michigan to distribution centres across the country, with the first shots expected to be given in the coming week to health care workers and at nursing homes. Yesterday, country music pioneer Charlie Pride died of complications from COVID-19 at 86; late last week, New Orleans stage and screen actor Carol Sutton died from complications at 76.
- The Mexican government’s medical safety commission approved the emergency use of the Pfizer-BioNTech coronavirus vaccine right before the weekend, making it the fourth country to do so.
- Britain’s AstraZeneca has agreed to buy U.S. drug maker Alexion Pharmaceuticals for US$39-billion in its largest deal, diversifying away from its fast-growing cancer business in a bet on rare-disease and immunology drugs.
- Meanwhile, Italy eclipsed Britain to become the nation with the worst official coronavirus death toll in Europe.
- Gary Mason: “As such, we now find ourselves at a crossroads: Do we allow encampments to exist more permanently but in less visible locations – made-in-Canada-style refugee camps – or do we finally attempt to solve homelessness in a meaningful way, with the massive financial investment that would entail?”
- Marcus Gee: “Vaccination is even safer and more effective now, given all the advances since Salk. Consider: It took a half century from the discovery of the poliovirus to the release of a vaccine.”
- Sophie Wilson: “Everyone is online because they have already chosen. They don’t want to see a doctor in person. They don’t want to catch COVID-19. They don’t want to wait, or drive into town.”
- David Parkinson: “There may be a pretty significant gap between clearing the path for consumers to spend their ample stockpiles of cash and them actually doing so.”
- Some older Canadians are opting to take their chances, and spend winter in Florida despite COVID-19 pandemic.
- COVID-19 pandemic has exposed deep flaws in Canadian philanthropy, fragility of non-profits
- Modelling shows that Canada is on track for 12,000 daily COVID-19 cases by January
- Cirque du Soleil hit with bruising debt rating, hurting outlook after COVID-19 collapse
- Owner of Bay Street’s top fitness clubs files for creditor protection as COVID-19 empties financial core
- Rob Carrick’s 10-point checklist of things you should have done by now to protect or improve your money situation. Tips for minimizing damage to your credit score; how to manage retirement anxiety during difficult times; and things to think about if you’re considering home delivery.
- Here are the expectations for self-isolation; tips for managing anxiety and protecting your mental health; and what to do if you think you have the virus. Wash your hands. How to break a bad habit (like touching your face). Is flying safe?
- The best foods to eat to maintain an immune system-friendly diet; and how to keep a healthy diet while working from home; four eating tips when working from home; and five mistakes that might cause you to gain unwanted weight. Here are the essentials to stock up on and how to shop safely for groceries; the best pantry staples and how to stop stress-eating. What to cook with rhubarb (aside from pie).
- Here’s what you should do if you are newly laid off; how to apply for CERB, EI, and other financial benefits; how the CRA might identify CERB fraud; and other coronavirus and employment questions answered. What to do if your employees don’t return to work because they want to collect CERB.
Sources: Canada data are compiled from government websites, Johns Hopkins University and COVID-19 Canada Open Data Working Group; international data are from Johns Hopkins.